GLP1R and obesity disorder: Summary of evidence (R9):Liraglutide, a GLP-1 RA with weight loss efficacy at 3.0 mg/day, had its effects on obesity and complications evaluated in the Satiety and Clinical Adiposity–Liraglutide Evidence (SCALE) programme.